Search Results 1071-1080 of 17358 for Neurotransmitter
The Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic has multiple laboratories exploring a range of research focus areas.
The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic healthcare professionals perform research to develop new treatments for atherosclerosis. They also study ways to reduce the risk of heart attacks ...
Publications. Mukhtar H, Iyer V, Demirel N, Bendel EC, Bjarnason H, Misra S. Embolotherapy for Pulmonary Arteriovenous Malformations in the Pediatric ...
Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.
Norgestrel is used to prevent pregnancy. It works by stopping a woman's egg from fully developing each month. The egg can no longer accept a sperm and ...
Identifying protein interactions in intracellular signaling. Dr. Sieck and his colleagues use confocal microscopy to image and characterize protein-protein ...
The nervous system includes the brain, spinal cord and nerves that control all the workings of the body. When something goes wrong with a part of your nervous ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.